Suppr超能文献

建立并鉴定永生化人肝细胞系,用于生物人工肝脏应用。

Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers.

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Biotechnol Lett. 2012 Dec;34(12):2183-90. doi: 10.1007/s10529-012-1025-1. Epub 2012 Aug 29.

Abstract

An immortalized human hepatocyte cell line, HepLi5, was established via transfection of Simian virus 40 large T antigen (SV40 LT) into primary human hepatocytes. The morphologic and functional characteristics of HepLi5 cells were evaluated. The expression of SV40 LT in HepLi5 cells was detected by reverse transcription-PCR (RT-PCR) and western blotting. mRNA expression of liver-enriched genes, including glutamine synthetase, albumin, and cytochrome P450 was detected via RT-PCR in HepLi5 cells. Activity of CYP1A2, one of the drug-metabolizing P450 enzymes, was detected. Subcutaneous injection of HepLi5 cells into nude mice did not induce tumors within 3 months. Short Tandem Repeat results confirmed the authenticity of the cell line. Clinical-grade quantities of HepLi5 cells could be harvested using large-scale culture in roller bottles after which their cellular function was significantly enhanced. Therefore, the immortalized HepLi5 cells are a suitable cell source for applications in bioartificial livers.

摘要

通过将猿猴病毒 40 大 T 抗原 (SV40 LT) 转染到原代人肝细胞中,建立了一个永生化的人肝细胞系 HepLi5。评估了 HepLi5 细胞的形态和功能特征。通过逆转录-聚合酶链反应 (RT-PCR) 和蛋白质印迹法检测 HepLi5 细胞中 SV40 LT 的表达。通过 RT-PCR 检测 HepLi5 细胞中肝富集基因(包括谷氨酰胺合成酶、白蛋白和细胞色素 P450)的 mRNA 表达。检测了一种药物代谢 P450 酶 CYP1A2 的活性。在 3 个月内,将 HepLi5 细胞皮下注射到裸鼠体内并未诱导肿瘤。短串联重复结果证实了细胞系的真实性。使用滚瓶进行大规模培养后,可以收获临床级数量的 HepLi5 细胞,从而显著增强其细胞功能。因此,永生化的 HepLi5 细胞是生物人工肝脏应用的合适细胞来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验